Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

Inhibikase Therapeutics, Inc.

Balance Sheet

Standardized | As Reported Annual | Quarterly
 
In millions, except per share itemsDec-31-22Dec-31-21Dec-31-20Dec-31-19Dec-31-18
   10-K10-K10-K10-KS-1/A
Assets  
Cash and equivalents  7.240.80.00.00.4
Accounts receivable, net      0.5
Other current assets  17.21.7 0.00.4
Total current assets  24.442.50.00.01.3
Property, plant, and equipment, net  0.2    
Total assets  24.942.514.8-0.22.8
   
Accounts payable  1.21.11.71.01.0
Accrued expenses    0.41.72.2
Short-term and curr portion of long-term debt   [+]0.10.00.00.10.2
Deferred revenues     1.40.3
Other current liabilities  2.43.02.6  
Total current liabilities  3.74.14.74.33.6
Long-term debt    0.30.3 
Other liabilities  0.2    
Total liabilities  3.94.15.04.53.6
   
Shareholders' equity   [+]21.038.49.8-4.7-0.8
Tangible shareholders' equity  21.038.49.8-4.7-0.8

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy